BOVICOX 1 LTR

Bovicox oral suspension contains 50 mg/ml of toltrazuril.
Designed for the treatment and prevention of coccidiosis (caused by Eimeria bovis or Eimeria zuernii) in housed heifer calves (for environmental reasons, do not use in calves over 80kg) and sheep (lambs) (caused by Eimeria crandallis and Eimeria ovinoidalis).

Active Ingredient: Toltrazuril.

Withdrawal Periods:

Cattle: Meat and offal: 63 days. Not authorised for use in lactating animals producing milk for human consumption.

Sheep: Meat and offal: 42 days. Not authorised for use in lactating sheep producing milk for human consumption.

Product Benefits:

Single dose administration and long acting

Active against all intracellular development stages of coccidian

Decrease in the incidence of clinical diarrhea

Better weight at weaning age

Practical and accurate dosing

Adequate and economical therapy

Suitable for use for both prevention and cure

To obtain maximum benefit, animals should be treated before the expected onset of clinical signs i.e. the “Pre-Patent Period”.